Cas 1345962-07-3,1-methyl-4-(3-bromo-4,5-dimethoxyphenyl)-5-(3-fluoro-4-ethoxyphenyl)imidazole hydrochloride

1345962-07-3

Post Buying Request

Basic information

Product Name: 1-methyl-4-(3-bromo-4,5-dimethoxyphenyl)-5-(3-fluoro-4-ethoxyphenyl)imidazole hydrochloride
Synonyms: 1-methyl-4-(3-bromo-4,5-dimethoxyphenyl)-5-(3-fluoro-4-ethoxyphenyl)imidazole hydrochloride
CAS NO:1345962-07-3
Molecular Formula:
Molecular Weight: 471.754
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-methyl-4-(3-bromo-4,5-dimethoxyphenyl)-5-(3-fluoro-4-ethoxyphenyl)imidazole hydrochloride(CAS DataBase Reference)
NIST Chemistry Reference: 1-methyl-4-(3-bromo-4,5-dimethoxyphenyl)-5-(3-fluoro-4-ethoxyphenyl)imidazole hydrochloride(1345962-07-3)
EPA Substance Registry System: 1-methyl-4-(3-bromo-4,5-dimethoxyphenyl)-5-(3-fluoro-4-ethoxyphenyl)imidazole hydrochloride(1345962-07-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1345962-07-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1345962-07-3 Suppliers

Recommended suppliers

1345962-07-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1345962-07-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,5,9,6 and 2 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1345962-07:
(9*1)+(8*3)+(7*4)+(6*5)+(5*9)+(4*6)+(3*2)+(2*0)+(1*7)=173
173 % 10 = 3
So 1345962-07-3 is a valid CAS Registry Number.

1345962-07-3Upstream product

1345962-07-3Downstream Products

1345962-07-3Relevant academic research and scientific papers

COMBRETASTATIN ANALOGS FOR USE IN THE TREATMENT OF CANCER

-

Page/Page column 41, (2011/11/30)

The present invention relates to specific analogs of combretastatin, in particular the compounds of formula (I) as described and defined herein, and pharmaceutical compositions comprising the compounds, as well as their medical use, in particular in the treatment or prevention of cancer, including multidrug-resistant cancer.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1345962-07-3